(Q45737739)

15 December 2017

title

Detection of Epstein--Barr virus-determined nuclear antigen-2 mRNA by in situ hybridization (English)

1 reference

15 December 2017

Shimakage M

1

1 reference

15 December 2017

Sasagawa T

series ordinal

2

1 reference

15 December 2017

publication date

1 April 2001

1 reference

Journal of Virological Methods

15 December 2017

published in

1 reference

15 December 2017

volume

93

1 reference

15 December 2017

issue

1-2

1 reference

15 December 2017

page(s)

23-32

1 reference

describes a project that uses

15 December 2017

in situ hybridization

1 reference

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Antibody Response Against the Epstein-Barr Virus-Coded Nuclear Antigen2 (EBNA2) in Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

A Ki-1-positive cell line expressing Epstein-Barr virus antigens, established from a child with Ki-1-positive lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Tumorigenicity of EBNA2-transfected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Increased sensitivity of EBNA2-transformed rat fibroblasts to ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Detection of Epstein-Barr virus transcripts in anaplastic large-cell lymphomas by mRNA in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Down-regulation of drs mRNA in human colon adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900271-8

7 January 2021

10.1016/S0166-0934(00)00271-8

Identifiers

DOI

1 reference

15 December 2017

1 reference